TSSLint 3, the lightweight TypeScript linting tool by Johnson Chu, enhances performance with a reduced dependencies and improved migration paths from legacy linters. As a spiritual successor to TSLint ...
The unified JavaScript runtime standard is an idea whose time has come. Here’s an inside look at the movement for server-side JavaScript interoperability.
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.
A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...
WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, designed to boost domestic drug supply by speeding ...
Health Secretary Robert F. Kennedy Jr. said addiction is a “spiritual disease” that calls out for the involvement of religious organizations. By Ellen Barry Health Secretary Robert F. Kennedy Jr.
In our Nioh 3 walkthrough, we will be going for a 100% Collectibles run. We'll also try to fight as many bosses as possible while doing every myth, mission, and battle scroll we can. We start off with ...
This desktop app for hosting and running LLMs locally is rough in a few spots, but still useful right out of the box. Dedicated desktop applications for agentic AI make it easier for relatively ...
GPT-5.3-Codex-Spark is a lightweight version of the company’s coding model, GPT-5.3-Codex, that is optimized to run on ultra-low latency hardware and can deliver over 1,000 tokens per second.
WASHINGTON, Feb 2 (Reuters) - California's proposed $200 million electric vehicle incentive program will be limited to first-time buyers and require participating manufacturers to contribute matching ...
Claude Code has pulled ahead of OpenAI's Codex in VS Code Marketplace adoption metrics for tools tagged with 'agent,' just one way to judge these tools for your particular needs in this rapidly ...
As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage drugs, including a gene therapy from its $1 billion acquisition of Prevail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results